Prezista Suspension
Product Images NDC 59676-565

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Prezista (NDC 59676-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Products Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Prezista 01)

Chemical structure of darunavir, the active ingredient in PREZISTA tablets. The structure includes multiple rings, functional groups such as hydroxyl, amide, and sulfonamide, and a labeled ethanol molecule (C2H5OH).*

FDA Label Image

Figure 1 (Prezista 02)

Two forest plot charts depicting geometric mean ratios (GMR) with 90% confidence intervals for PREZISTA (darunavir) pharmacokinetic parameters during the second and third trimesters of pregnancy. Parameters shown include total and unbound AUC and Cmin for twice daily and once daily dosing regimens, illustrating comparisons of drug exposure across trimesters.*

FDA Label Image

Figure (Prezista 03)

An instructional diagram showing a bottle, a syringe with labeled barrel and plunger, and an adapter piece. This illustration likely demonstrates the components used for measuring and administering liquid medication from a bottle using a syringe and adapter.*

FDA Label Image

Figure A (Prezista 04)

An instructional illustration showing a hand holding a bottle upright, with arrows indicating to shake the bottle up and down. This diagram suggests the proper method to shake the product before use.*

FDA Label Image

Figure B (Prezista 05)

An instructional illustration showing how to open a child-resistant bottle cap. The first panel demonstrates twisting the cap counterclockwise, and the second panel shows lifting the cap off the bottle after twisting.*

FDA Label Image

Figure C (Prezista 06)

An instructional illustration showing the steps to open and prepare a bottle for use. The first image depicts a hand unscrewing the cap from a bottle, the second image shows hands holding the bottle near a cup filled with liquid, and the third image shows the bottle without a cap, partially filled with liquid inside.*

FDA Label Image

Figure D (Prezista 07)

An instructional illustration showing a hand holding a bottle while another hand uses a syringe to withdraw liquid from the bottle, indicated by a downward arrow suggesting the syringe insertion direction.*

FDA Label Image

Figure E (Prezista 08)

An instructional line drawing showing a person holding a bottle upside down and drawing liquid into a syringe from the bottle. The image depicts a step in medication preparation for oral administration.*

FDA Label Image

Figure F (Prezista 09)

Illustration showing a person withdrawing liquid from a bottle using a syringe. The left panel depicts the syringe inserted into the bottle, while the right panel shows the syringe being pulled upward to draw the liquid out. The images demonstrate proper technique for using a syringe to extract medication from a vial or bottle.*

FDA Label Image

Figure G (Prezista 10)

Illustration showing a person administering an oral medication using an oral syringe. The syringe is held near the mouth, demonstrating the dosing method by mouth.*

FDA Label Image

Figure H (Prezista 11)

An instructional illustration showing a hand turning the child-resistant cap of a bottle counterclockwise to open it. The image demonstrates the proper way to open a safety cap by gripping and twisting.*

FDA Label Image

Figure I (Prezista 12)

An instructional illustration showing two hands pulling apart a syringe and its protective cap, with double-headed arrows indicating separation. This likely demonstrates how to remove the syringe cap before use.*

FDA Label Image

Figure J (Prezista 12a)

An instructional illustration showing one hand holding a syringe while a second hand pulls back the plunger, indicated by a bold arrow pointing upward. This image demonstrates proper syringe preparation technique.*

FDA Label Image

Principal Display Panel (75 mg Tablet Bottle Label)

Label for PREZISTA (darunavir) tablets 75 mg, a human prescription oral film-coated tablet manufactured by Janssen Products LP and Janssen Therapeutics. The label indicates a quantity of 480 tablets, with NDC 59676-563-01, and includes storage and dosage instructions along with manufacturer information.*

FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

The packaging label for PREZISTA (darunavir) tablets shows a 150 mg film-coated tablet strength. The label indicates a 240-tablet Rx-only package with the NDC 59676-564-01. The product is manufactured by Janssen Products LP. There is a green alert box advising not to take certain medicines with PREZISTA. Additional dosage and storage instructions are included on the label.*

FDA Label Image

Principal Display Panel (600 mg Tablet Bottle Label)

PREZISTA 600 mg film-coated tablets label showing a 60-tablet prescription drug package by Janssen Products LP. The label includes the NDC 59676-562-01, the generic name darunavir, dosage information, and manufacturer details. Warning information about drug interactions and storage instructions are also visible.*

FDA Label Image

Principal Display Panel (800 mg Tablet Bottle Label)

PREZISTA 800 mg (darunavir) tablets, film-coated, available in a bottle of 30 tablets. The label includes dosage form and strength, NDC 59676-566-30, manufacturer Janssen Products LP, and an alert about medicines that should not be taken with PREZISTA. It also features storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (200 mL Bottle Carton)

The image shows the packaging label for PREZISTA (darunavir) Oral Suspension, 100 mg per mL in a 200 mL bottle. The label includes storage instructions, cautions like refrigerate and freeze avoidance, and dosing recommendations referring to prescribing information. It also displays the Janssen logo and states the product is Rx only, manufactured by Janssen Pharmaceutica NV and Janssen Therapeutics.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.